Article
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
- OneMedNet (NASDAQ:ONMD) stock moved upwards by 78.5% to $1.26 during Friday's regular session. The company's market cap stands at $35.9 million.
- Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 62.0% to $0.64. The company's market cap stands at $1.3 million.
- Edesa Biotech (NASDAQ:EDSA) shares increased by 43.88% to $2.23. The company's market cap stands at $12.9 million.
- Neurogene (NASDAQ:NGNE) stock rose 33.13% to $26.2. The market value of their outstanding shares is at $304.8 million.
- Klotho Neurosciences (NASDAQ:KLTO) stock rose 22.82% to $0.59. The company's market cap stands at $34.6 million.
- Relay Therapeutics (NASDAQ:RLAY) shares moved upwards by 19.85% to $10.98. The market value of their outstanding shares is at $1.5 billion. The company's, Q4 earnings came out yesterday.
Losers
- Fulgent Genetics (NASDAQ:FLGT) shares decreased by 36.1% to $15.81 during Friday's regular session. The company's market cap stands at $765.3 million. As per the press release, Q4 earnings came out today.
- Modular Medical (NASDAQ:MODD) stock declined by 27.87% to $0.32. The company's market cap stands at $34.1 million.
- Ginkgo Bioworks Holdings (NYSE:DNA) shares fell 24.72% to $7.31. The market value of their outstanding shares is at $588.3 million. The company's, Q4 earnings came out yesterday.
- Emergent BioSolutions (NYSE:EBS) stock declined by 22.84% to $8.56. The company's market cap stands at $582.9 million. The company's, Q4 earnings came out yesterday.
- Progyny (NASDAQ:PGNY) shares declined by 22.48% to $17.25. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q4 earnings report came out yesterday.
- Puma Biotechnology (NASDAQ:PBYI) shares fell 21.45% to $5.97. The company's market cap stands at $382.9 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Comments
- No comments yet. Be the first to comment!